Lotus Eye Hospital And Institute Ltd (IN:LOTUSEYE)
:LOTUSEYE
LOTUSEYE Stock Chart & Stats
₹118.10
-₹0.92(-1.30%)
At close: 4:00 PM EST
₹118.10
-₹0.92(-1.30%)
Day’s Range― - ―
52-Week Range₹64.00 - ₹147.60
Previous CloseN/A
Volume15.88K
Average Volume (3M)2.23K
Market Cap
₹2.27B
Enterprise Value₹2.27B
Total Cash (Recent Filing)₹32.49M
Total Debt (Recent Filing)₹47.99M
Price to Earnings (P/E)―
Beta0.92
Next Earnings
May 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.13
Shares Outstanding20,796,330
10 Day Avg. Volume4,541
30 Day Avg. Volume2,230
Financial Highlights & Ratios
PEG Ratio-2.60
Price to Book (P/B)2.43
Price to Sales (P/S)2.94
P/FCF Ratio-68.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Specialist Ophthalmology ModelA focused, specialty eye-hospital chain creates durable competitive advantage via clinical expertise, standardized protocols and referral-driven volumes. Specialization supports higher repeatable procedure throughput, reputation-based patient acquisition and easier operational scaling within the niche over years.
Consistent Revenue ExpansionSustained top-line growth across multiple years indicates expanding service adoption and market penetration. Persistent revenue expansion provides capacity to invest in facilities and talent, supports long-term margin recovery programs, and underpins strategic investments without relying solely on capital markets.
Robust Balance Sheet And Low LeverageA strong equity base and low leverage give the company durable financial flexibility to fund expansion, absorb demand shocks and finance capex internally. Prudent leverage reduces refinancing risk and preserves strategic optionality for partnerships or acquisitions over the medium term.
Bears Say
Severe Gross Margin CompressionA multi-year collapse in gross margin signals persistent cost pressures or unfavorable service mix that erode the core economics of procedures. If structural, lower gross margins make it harder to convert revenue into sustainable profitability and constrain reinvestment capacity.
Negative Free Cash Flow From CapexNegative free cash flow driven by rising capex reduces internal funding for operations and growth, increasing reliance on external financing or equity. Over months, persistent negative FCF can pressure liquidity and limit ability to fund expansion without higher leverage or dilution.
Volatile Operating Cash GenerationFluctuating operating cash flow implies less predictable cash conversion from core operations, complicating planning for recurring expenses and capex. Combined with negative FCF and margin erosion, unstable OCF raises execution risk for multi-quarter strategies and working-capital management.
Lotus Eye Hospital And Institute Ltd News
LOTUSEYE FAQ
What was Lotus Eye Hospital And Institute Ltd’s price range in the past 12 months?
Lotus Eye Hospital And Institute Ltd lowest stock price was ₹64.00 and its highest was ₹147.60 in the past 12 months.
What is Lotus Eye Hospital And Institute Ltd’s market cap?
Lotus Eye Hospital And Institute Ltd’s market cap is ₹2.27B.
When is Lotus Eye Hospital And Institute Ltd’s upcoming earnings report date?
Lotus Eye Hospital And Institute Ltd’s upcoming earnings report date is May 27, 2026 which is in 42 days.
How were Lotus Eye Hospital And Institute Ltd’s earnings last quarter?
Lotus Eye Hospital And Institute Ltd released its earnings results on Feb 11, 2026. The company reported -₹0.125 earnings per share for the quarter, missing the consensus estimate of N/A by -₹0.125.
Is Lotus Eye Hospital And Institute Ltd overvalued?
According to Wall Street analysts Lotus Eye Hospital And Institute Ltd’s price is currently Overvalued.
Does Lotus Eye Hospital And Institute Ltd pay dividends?
Lotus Eye Hospital And Institute Ltd pays a Annually dividend of ₹0.5 which represents an annual dividend yield of N/A. See more information on Lotus Eye Hospital And Institute Ltd dividends here
What is Lotus Eye Hospital And Institute Ltd’s EPS estimate?
Lotus Eye Hospital And Institute Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lotus Eye Hospital And Institute Ltd have?
Lotus Eye Hospital And Institute Ltd has 20,796,330 shares outstanding.
What happened to Lotus Eye Hospital And Institute Ltd’s price movement after its last earnings report?
Lotus Eye Hospital And Institute Ltd reported an EPS of -₹0.125 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.112%.
Which hedge fund is a major shareholder of Lotus Eye Hospital And Institute Ltd?
Currently, no hedge funds are holding shares in IN:LOTUSEYE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Lotus Eye Hospital And Institute Ltd
Lotus Eye Hospital and Institute Limited, an eye hospital, provides eye care services in India. It offers services in the areas of refractive surgery, retina and uvea, cornea, glaucoma, paediatric and squint, computer vision syndrome, orbit and oculoplasty, neuro ophthalmology, and binocular vision. The company also provides cataract and intraocular lenses, as well as operates an eye bank. In addition, it offers ophthalmic fellowship training courses in cornea, glaucoma, retina, and anterior segments, as well as DNB teaching and training services. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was incorporated in 1997 and is based in Coimbatore, India.
Technical Analysis
Gkb Ophthalmics Limited
―
HealthCare Global Enterprises Ltd.
―
Krsnaa Diagnostics Limited
―
Shalby Ltd.
―
Vijaya Diagnostic Centre Ltd.
―